Oncothyreon (ONTY) -5.1% AH after announcing a stock offering of undisclosed size. The company...

|By:, SA News Editor

Oncothyreon (ONTY) -5.1% AH after announcing a stock offering of undisclosed size. The company plans to use the proceeds to fund the development of its PX-866 cancer drug, as well as its ONT-10 vaccine. (PR)